nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—hypertension—focal segmental glomerulosclerosis	0.989	1	CtDrD
Fenoldopam—ADRA2C—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	1.86e-05	0.00172	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	1.85e-05	0.00171	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.84e-05	0.0017	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	1.83e-05	0.00169	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	1.82e-05	0.00168	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.81e-05	0.00167	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	1.81e-05	0.00167	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.8e-05	0.00167	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.79e-05	0.00166	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.79e-05	0.00166	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	1.77e-05	0.00163	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	1.74e-05	0.00161	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	1.74e-05	0.00161	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	1.73e-05	0.0016	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	1.72e-05	0.00159	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.72e-05	0.00159	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.71e-05	0.00158	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.69e-05	0.00157	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	1.69e-05	0.00156	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	1.68e-05	0.00156	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.68e-05	0.00156	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.68e-05	0.00155	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	1.68e-05	0.00155	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.67e-05	0.00155	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.66e-05	0.00154	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	1.66e-05	0.00153	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.65e-05	0.00153	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.64e-05	0.00152	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.63e-05	0.00151	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	1.62e-05	0.0015	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	1.61e-05	0.00149	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.61e-05	0.00149	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	1.6e-05	0.00148	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.6e-05	0.00148	CbGpPWpGaD
Fenoldopam—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.59e-05	0.00147	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	1.58e-05	0.00146	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.58e-05	0.00146	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—FN1—focal segmental glomerulosclerosis	1.56e-05	0.00145	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.55e-05	0.00144	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.55e-05	0.00143	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	1.55e-05	0.00143	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.55e-05	0.00143	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	1.53e-05	0.00141	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.53e-05	0.00141	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.53e-05	0.00141	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	1.52e-05	0.00141	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.52e-05	0.00141	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.52e-05	0.00141	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.51e-05	0.0014	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	1.51e-05	0.00139	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.51e-05	0.00139	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	1.5e-05	0.00139	CbGpPWpGaD
Fenoldopam—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.49e-05	0.00138	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	1.47e-05	0.00136	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.47e-05	0.00136	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—FN1—focal segmental glomerulosclerosis	1.46e-05	0.00135	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.45e-05	0.00135	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.45e-05	0.00134	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.45e-05	0.00134	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.44e-05	0.00133	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	1.44e-05	0.00133	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.43e-05	0.00132	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.42e-05	0.00131	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	1.42e-05	0.00131	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.41e-05	0.0013	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.41e-05	0.0013	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.4e-05	0.0013	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.4e-05	0.00129	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.39e-05	0.00128	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.38e-05	0.00128	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.38e-05	0.00127	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	1.37e-05	0.00127	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	1.36e-05	0.00126	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.36e-05	0.00125	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.35e-05	0.00125	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.33e-05	0.00123	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.31e-05	0.00121	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.3e-05	0.0012	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.3e-05	0.0012	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—ALB—focal segmental glomerulosclerosis	1.3e-05	0.0012	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.3e-05	0.0012	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.29e-05	0.00119	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.29e-05	0.00119	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.29e-05	0.00119	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.28e-05	0.00118	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.27e-05	0.00117	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	1.26e-05	0.00117	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.24e-05	0.00115	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.23e-05	0.00114	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.23e-05	0.00114	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—LIPC—focal segmental glomerulosclerosis	1.23e-05	0.00114	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.22e-05	0.00112	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—ALB—focal segmental glomerulosclerosis	1.21e-05	0.00112	CbGpPWpGaD
Fenoldopam—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.21e-05	0.00112	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.2e-05	0.00111	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.2e-05	0.00111	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.2e-05	0.00111	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.19e-05	0.0011	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	1.19e-05	0.0011	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.18e-05	0.0011	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.18e-05	0.0011	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.18e-05	0.00109	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.18e-05	0.00109	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.17e-05	0.00109	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.17e-05	0.00108	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.17e-05	0.00108	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.17e-05	0.00108	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.17e-05	0.00108	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	1.15e-05	0.00107	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	1.14e-05	0.00106	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.13e-05	0.00105	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.13e-05	0.00104	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.1e-05	0.00102	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.09e-05	0.00101	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.09e-05	0.00101	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.09e-05	0.00101	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CTGF—focal segmental glomerulosclerosis	1.08e-05	0.000999	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.08e-05	0.000995	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.08e-05	0.000995	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.07e-05	0.000992	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.07e-05	0.000989	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.07e-05	0.000986	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.06e-05	0.00098	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.05e-05	0.000973	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.05e-05	0.000968	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1e-05	0.000925	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	9.99e-06	0.000924	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	9.97e-06	0.000922	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	9.96e-06	0.000921	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.96e-06	0.000921	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.92e-06	0.000917	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	9.9e-06	0.000916	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.87e-06	0.000913	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	9.87e-06	0.000913	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	9.85e-06	0.000911	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	9.83e-06	0.000909	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	9.8e-06	0.000907	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	9.78e-06	0.000904	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	9.75e-06	0.000901	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.71e-06	0.000898	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.69e-06	0.000896	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.55e-06	0.000884	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.15e-06	0.000846	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.07e-06	0.000839	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	9.06e-06	0.000838	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	9.04e-06	0.000836	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.03e-06	0.000835	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.99e-06	0.000831	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.96e-06	0.000828	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	8.93e-06	0.000826	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.91e-06	0.000824	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	8.88e-06	0.000821	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	8.78e-06	0.000812	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.73e-06	0.000808	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.71e-06	0.000805	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.66e-06	0.000801	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.33e-06	0.00077	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	8.23e-06	0.000761	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	8.21e-06	0.00076	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.19e-06	0.000758	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.15e-06	0.000754	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.11e-06	0.00075	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.09e-06	0.000748	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.09e-06	0.000748	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.04e-06	0.000744	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.93e-06	0.000733	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.76e-06	0.000718	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	7.67e-06	0.00071	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.66e-06	0.000708	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.62e-06	0.000704	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.56e-06	0.000699	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.53e-06	0.000696	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.49e-06	0.000693	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	7.49e-06	0.000693	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.45e-06	0.000689	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.43e-06	0.000687	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.37e-06	0.000681	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.28e-06	0.000673	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.13e-06	0.000659	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.04e-06	0.000651	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.91e-06	0.000639	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.91e-06	0.000639	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.76e-06	0.000625	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.71e-06	0.00062	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.66e-06	0.000616	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.46e-06	0.000597	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.44e-06	0.000596	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	6.41e-06	0.000593	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.35e-06	0.000588	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.35e-06	0.000588	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.35e-06	0.000587	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.26e-06	0.000579	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.23e-06	0.000576	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.19e-06	0.000572	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.17e-06	0.00057	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	6.08e-06	0.000563	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.95e-06	0.00055	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.93e-06	0.000549	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.87e-06	0.000543	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.86e-06	0.000542	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.84e-06	0.00054	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.74e-06	0.000531	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.71e-06	0.000528	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.68e-06	0.000526	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.64e-06	0.000522	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.48e-06	0.000506	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.38e-06	0.000498	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.36e-06	0.000496	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.3e-06	0.00049	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.27e-06	0.000488	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.24e-06	0.000485	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	5.21e-06	0.000481	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.19e-06	0.00048	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.09e-06	0.000471	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.95e-06	0.000458	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.95e-06	0.000458	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	4.92e-06	0.000455	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.89e-06	0.000452	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.87e-06	0.000451	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.86e-06	0.00045	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.82e-06	0.000446	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.7e-06	0.000435	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.68e-06	0.000433	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.49e-06	0.000415	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.41e-06	0.000408	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.35e-06	0.000403	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.33e-06	0.0004	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.12e-06	0.000381	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.06e-06	0.000375	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.02e-06	0.000372	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	3.99e-06	0.000369	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.79e-06	0.000351	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.74e-06	0.000346	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.74e-06	0.000346	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.6e-06	0.000333	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.38e-06	0.000312	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.35e-06	0.000309	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.16e-06	0.000292	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.13e-06	0.000289	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.11e-06	0.000287	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.08e-06	0.000285	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.86e-06	0.000265	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.78e-06	0.000258	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.76e-06	0.000255	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.6e-06	0.000241	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.56e-06	0.000237	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.56e-06	0.000237	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.36e-06	0.000218	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.27e-06	0.00021	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.11e-06	0.000195	CbGpPWpGaD
